Lv3
396 积分 2023-04-11 加入
Accelerating scientific discovery with Co-Scientist
1天前
已完结
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age–related macular degeneration: real world data from the Fight Retinal Blindness registry
13天前
已完结
Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!
13天前
已完结
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)
13天前
已完结
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti–VEGF Drug Type for 1 Year in the IRIS Registry
13天前
已完结
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
29天前
已完结
Interleukin-1 blockade in cardiovascular diseases: a clinical update
29天前
已完结
Autolytic degradation of ocriplasmin: a complex mechanism unraveled by mutational analysis
1个月前
已完结
Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
皖公网安备34019202002308
